Stella Diagnostics Inc.
SLDX · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $201 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $326 | $0 | $0 | $0 |
| Gross Profit | -$125 | $0 | $0 | $0 |
| % Margin | -62.2% | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $491 | $327 | $186 | $192 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $491 | $327 | $186 | $192 |
| Operating Income | -$616 | -$327 | -$186 | -$284 |
| % Margin | -306.2% | – | – | – |
| Other Income/Exp. Net | -$31 | $97 | -$94 | -$137 |
| Pre-Tax Income | -$647 | -$230 | -$280 | -$330 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$647 | -$230 | -$280 | -$330 |
| % Margin | -321.5% | – | – | – |
| EPS | -0.002 | -0.001 | -0.001 | -0.001 |
| % Growth | -166.7% | 14.3% | 12.5% | – |
| EPS Diluted | -0.002 | -0.001 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 401,600 | 401,600 | 401,600 | 401,600 |
| Weighted Avg Shares Out Dil | 401,600 | 401,600 | 401,600 | 401,600 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $148 | $0 | $0 |
| Interest Expense | $31 | $0 | $43 | $35 |
| Depreciation & Amortization | $0 | $0 | $0 | -$102 |
| EBITDA | -$616 | -$230 | -$237 | -$385 |
| % Margin | -306.2% | – | – | – |